Evidence map›Paper›PMID 35927311›Full record

ArticleScientific reports2022

Corrosion inhibition of a novel antihistamine-based compound for mild steel in hydrochloric acid solution: experimental and computational studies.

Mohammad Ghaderi, Ahmad Ramazani S A, Azadeh Kordzadeh, Mohammad Mahdavian, Eiman Alibakhshi, Arash Ghaderi

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Mohammad GhaderiDepartment of Chemical and Petroleum Engineering, Sharif University of Technology, Tehran, Iran.
Ahmad Ramazani S ADepartment of Chemical and Petroleum Engineering, Sharif University of Technology, Tehran, Iran. ramazani@sharif.edu.
Azadeh KordzadehDepartment of Chemical and Petroleum Engineering, Sharif University of Technology, Tehran, Iran.
Mohammad MahdavianSurface Coating and Corrosion Department, Institute for Color Science and Technology, Tehran, Iran. mahdavian-m@icrc.ac.ir.
Eiman AlibakhshiSurface Coating and Corrosion Department, Institute for Color Science and Technology, Tehran, Iran.
Arash GhaderiDepartment of Chemistry, College of Sciences, University of Hormozgan, Bandar Abbas, 7916193145, Iran.
Sharif University of Technology · IRHormozgan University · IRInstitute for Color Science and Technology · IRMedical Protective · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Focused on the assessment of the diphenhydramine hydrochloride (DPH) capabilities as an alternative to conventional and harmful industrial corrosion inhibitors, electrochemical techniques were employed. The optimum concentration of 1000 ppm was determined by molecular simulation and validated through electrochemical experiments. The results acquired from the electrochemical impedance spectroscopy (EIS) study showed that DPH at a concentration of 1000 ppm has a corrosion efficiency of 91.43% after 6 h immersion. The DPH molecules' orientation on the surface was assessed based on EIS predicting horizontal adsorption on the surface. Molecular simulations were done to explore the adsorption mechanism of DPH. The DPH molecules' orientation on the surface was also assessed based on computational studies confirming the horizontal adsorption predicted by EIS.

Indexed as

Hydrochloric AcidSteelAdsorptionCorrosionHistamine AntagonistsHistamine AntagonistsHydrochloric AcidSteel

Identifiers

PMID35927311
PMCPMC9352695
OpenAlexW4289782369

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.